Nasrin Perskvist,
National Coordinator and Director of
Clinical Cytology Biobank
BBMRI.se
Karolinska Institute, Inst LabMed
Karolinska University Hospital
Clinical Pathology Cytology
[email protected],
BBMRI.se
Karolinsk
Institut
Karolinska
University
hospital
This is the outcome of
a wonderful and
synergic cooperation
Umeå
Karolinska
Örebro
Göteborg
BBMRI.se
Biobanking and
Molecular Resource
Infrastructure of
Sweden
Östersund
Sunderby
Umeå
Sundsvall
At present the total number of
biobanked Gynecological cell samples on a
common platform and nation wide is 780
000 cell samples .
Karlstad
Göteborg
Nasrin Perskvist:
 Project leader for development of
Cytology Biobank
 National Coordinator
 Director of the Cytology Biobank at
Karolinska, Headquarter
Gävle
Falun
Average handled 65% of the total cell samples in
the country annually
Örebro
Västerås
Stockholm
Linköping
Lund
Process of Moving of the biobank from
regionally to Nation wide
 August 2011; Inauguration of the Cytology Biobank
at Karolinska Stockholm (Start date)
 Summer 2012; Purchase the second biobank system
and implemented at the site of Karolinska
 Autumn 2012; Lancing and Implementation of the Biobank
at site of Sahlgrenska Hospital in Göteborg
 Spring 2013; Upgrading entire sample handling system
of the biobank nation wideAt the Headquarter-Karolinska
 Spring 2013; Lancing and implantation of the Cytology
Biobank at the site of Örebro University Hospital
Contact person: Joakim Dillner and
Nasrin Perskvist
Karolinska University Hospital
Contact person: Joakim Dillner
Nasrin Perskvist
Karolinska University Hospital
Contact person:
Peter Horal and Katarina Johansson
Clinical Mikrobiolog Departement at
Sahlgrenska
Contact person: Nasrin Perskvist
Karolinska University Hospital
Contact person: Mats Karlsson
and Helena Issaksson
Laboratory Medicine , Örebro Hospital
Process of Moving of the biobank from
regionally to Nation wide
 Autumn 2013; Lancing and implantation of the Cytology
Biobank at the site of Umeå University Hospital
 Autumn 2014; Agreement of lancing second Biobank system
at site of Sahlgrenska Hospital in Göteborg.
February 2015 implemented, ready in Routine
 Winter 2014; Agreement of lancing second Biobank system
at site of Umeå University Hospital
Mars 2015 Implemented and ready in Routine
Contact person: Gun Jakobsson,
Marko Korpela,
Anna Knuts Noudot
Laboratoriemedicin, Norrlands
Universitetssjukhuset, Umeå
Contact person:
Peter Horal and Katarina Johansson
Clinical Mikrobiolog Departement at
Sahlgrenska
Contact person: Gun Jakobsson,
Marko Korpela,
Anna Knuts Noudot
Laboratoriemedicin, Norrlands
Universitetssjukhuset, Umeå
The biobank´s activities during 2014 and onward
Antal ingående biobankad
cellprover
Start datum (slutdatum)
Studienamn (Fenotyp)
Ansvarig forskare (hemort)
Utvärdering av falskt negativa i HPV
primärscreeningen.
Genotypning av HPV för klinisk handläggning
Anders Hjerpe
Karolinska sjukhuset
1000-5000
2014-10-30
(Pågående)
Kristina Elfgren
Kvinnokliniken, Karolinska sjukhuset
1000-3000
2014-10-30
(Pågående)
Förekomst av högrisk HPV på lagrade LBC-prover
Ingrid Norman, Klinisk Cytologi,
Karolinska sjukhuset
100-1000
2014-10-30
(Pågående)
RT-Långförvaringseffekt på LBC-prover innan
biobankning
Nasrin Perskvist
Cytologibiobank Karolinska Sjukhuset
500-1000
2014-12-01
(Pågående)
Kvalitetskontrol av lagrade LBC-prover för HPV
Nasrin Perskvist
Cytologibiobank Karolinska Sjukhuset
500-1000
2012-01-01
(2014-12-15)
Kvalitetskontroll av lagrade LBC-prover för
morfologisk diagnostik
Validering av diagnostik kit för Ki67 och p16
Nasrin Perskvist
Cytologibiobank Karolinska Sjukhuset
500-1000
2012-01-01
(2014-12-15)
Roche Ventana
Stockholm- Sverige
100-1000
2014-11-01
(Pågående)
Genetiska studier av hemofagocyterande
lymfohistiocytos i association med
malignitet
Biobanksbaserad studie av biomarkörer för
livmoderhalscancer
Jan-Inge Henter och Marie Meets,
Barncancerforskningsenheten,
Karolinska sjukhuset och KI biobank
5000-10000
2014-11-01
(Pågående)
Joakim Dillner
Karolinska sjukhuset
1000-5000
2014-08-01
(Pågående)
Prediktion av Kvinnocancer med OMICS teknik att
individualisera screening och prevention
Prof Martin Widschwendter,
University College London
5000-10000
2014-08-01
(Pågående)
Bio/Medicinska utbildningar 2013Framåt
BMA-Sjuksköterskeutbildning
Klinisk omdiagnostisering 2013 framåt
Nasrin Perskvist
Cytologibiobank Karolinska Sjukhuset
Kontinuerligt
Kontinuerligt
Klinisk Patologi-Cytologi
Kontinuerligt
Kontinuerligt
Financial income (intäkter) of the Cytology Biobank to SLL and BBMRI.se 2014 and onward
 subsidized requisition from Sahlgrenska to BBMRI.se
subsidized requisition from Umeå Hospital to BBMRI.se
50% of total sum
50% of total sum
 Financial Income from research groups provided by Cytology Biobank
 Financial income from the KI-university education of Nursing and BMA provided
academic courses by Cytology Biobank
Cytology Biobank activities updated
Vital to connect together Clinical Cytological Laboratories Nation Wide
 Autumn 2011
Nationell Cytologibiobank 1:a Nationell Hearing
 April 2012
Nordic BBMRI WP3 meeting:
Clinical Biobanking in the Nordic Countries
 Spring 2012
First User Meeting (Användarmöte)Karolinska
 Spring 2013
Nationell Cytologibiobank 2:a Nationell Hearing
 Autumn 2013
Second User Meeting, Göteborg
 Winter 2014
Third User Meeting, Karolinska
 Autumn 2015
3:a Nationell Hearing
 Autumn 2015
Forth User Meeting, Karolinska
 Connection of laboratories
Nation Wide Connection Between Laboratories
Östersund
Sunderby
Umeå
Sundsvall
Gävle
Falun
Karlstad
Göteborg
Örebro
Västerås
Stockholm
Linköping
Lund
Systematic Biobanking in Clinical Laboratory Medicine
Clinical Chemistry
Clinical Microbiology
Clinical Immunology
Clinical Pharmacology
Clinical
Lab-Med
Clinical Pathology
Clinical Virology
Clinical Cytology
Clinical Genetic
The Stat-of-Art in Clinical Laboratory Medicine
in Health Care System